A Broad Spectrum Antiparasitic Activity of Organotin (IV) Derivatives and Its Untargeted Proteomic Profiling Using Leishmania donovani
- PMID: 36558759
- PMCID: PMC9785441
- DOI: 10.3390/pathogens11121424
A Broad Spectrum Antiparasitic Activity of Organotin (IV) Derivatives and Its Untargeted Proteomic Profiling Using Leishmania donovani
Abstract
Metals have been used in medicine since ancient times for the treatment of different ailments with various elements such as iron, gold and arsenic. Metal complexes have also been reported to show antibiotic and antiparasitic activity. In this context, we tested the antiparasitic potential of 10 organotin (IV) derivatives from 4-(4-methoxyphenylamino)-4 oxobutanoic acid (MS26) against seven eukaryotic pathogens of medical importance: Leishmania donovani, Trypanosoma cruzi, Trypanosoma brucei, Entamoeba histolytica, Giardia lamblia, Naegleria fowleri and Schistosoma mansoni. Among the compounds with and without antiparasitic activity, compound MS26Et3 stood out with a 50% effective concentration (EC50) of 0.21 and 0.19 µM against promastigotes and intracellular amastigotes of L. donovani, respectively, 0.24 µM against intracellular amastigotes of T. cruzi, 0.09 µM against T. brucei, 1.4 µM against N. fowleri and impaired adult S. mansoni viability at 1.25 µM. In terms of host/pathogen selectivity, MS26Et3 demonstrated relatively mild cytotoxicity toward host cells with a 50% viability concentration of 4.87 µM against B10R cells (mouse monocyte cell line), 2.79 µM against C2C12 cells (mouse myoblast cell line) and 1.24 µM against HEK923 cells (human embryonic kidney cell line). The selectivity index supports this molecule as a therapeutic starting point for a broad spectrum antiparasitic alternative. Proteomic analysis of host cells infected with L. donovani after exposure to MS26Et3 showed a reduced expression of Rab7, which may affect the fusion of the endosome with the lysosome, and, consequently, impairing the differentiation of L. donovani to the amastigote form. Future studies to investigate the molecular target(s) and mechanism of action of MS26Et3 will support its chemical optimization.
Keywords: antiparasitic activity; drug discovery; neglected tropical diseases; organotin (IV) compounds.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Design, synthesis and biological evaluation of antiparasitic dinitroaniline-ether phospholipid hybrids.Bioorg Chem. 2023 Sep;138:106615. doi: 10.1016/j.bioorg.2023.106615. Epub 2023 May 19. Bioorg Chem. 2023. PMID: 37244229
-
Antiparasitic chemotherapy: tinkering with the purine salvage pathway.Adv Exp Med Biol. 2008;625:116-32. doi: 10.1007/978-0-387-77570-8_10. Adv Exp Med Biol. 2008. PMID: 18365663 Review.
-
An Antiparasitic Compound from the Medicines for Malaria Venture Pathogen Box Promotes Leishmania Tubulin Polymerization.ACS Infect Dis. 2020 Aug 14;6(8):2057-2072. doi: 10.1021/acsinfecdis.0c00122. Epub 2020 Jul 20. ACS Infect Dis. 2020. PMID: 32686409 Free PMC article.
-
Multi-target withaferin-A analogues as promising anti-kinetoplastid agents through the programmed cell death.Biomed Pharmacother. 2023 Aug;164:114879. doi: 10.1016/j.biopha.2023.114879. Epub 2023 May 19. Biomed Pharmacother. 2023. PMID: 37210899
-
Promising antiparasitic agents from marine sponges.Saudi J Biol Sci. 2022 Jan;29(1):217-227. doi: 10.1016/j.sjbs.2021.08.068. Epub 2021 Aug 26. Saudi J Biol Sci. 2022. PMID: 35002412 Free PMC article. Review.
Cited by
-
Targeting Cutaneous Leishmaniasis with Thiadiazine Thione Derivatives: An In Vivo Study of Its Anti-Inflammatory, Anti-Pyretic, Anti-Nociceptive, and Anti-Sedative Properties.Biomedicines. 2025 Jan 3;13(1):93. doi: 10.3390/biomedicines13010093. Biomedicines. 2025. PMID: 39857677 Free PMC article.
-
Environmental and socio-demographic factors associated with cutaneous leishmaniasis in district Khyber, Pakistan; alarming spread of the disease to new foci.Heliyon. 2024 Apr 16;10(8):e29571. doi: 10.1016/j.heliyon.2024.e29571. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38681643 Free PMC article.
-
Establishment of THTT derivatives as potential antileishmanial and anti-inflammatory agents through in vitro and in silico investigations.Sci Rep. 2025 Aug 2;15(1):28246. doi: 10.1038/s41598-025-12084-6. Sci Rep. 2025. PMID: 40753261 Free PMC article.
References
-
- Gielen M., Tiekink E.R. Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine. John Wiley & Sons; Hoboken, NJ, USA: 2005.
-
- Boechat N., Kover W.B., Bastos M.M., Romeiro N.C., Silva A.S.C., Santos F.C., Valverde A., Azevedo M.L.G., Wollinger W., Souza T.M.L., et al. Design, synthesis, and biological evaluation of new 3-hydroxy-2-oxo-3-trifluoromethylindole as potential HIV-1 reverse transcriptase inhibitors. Med. Chem. Res. 2007;15:492–510. doi: 10.1007/s00044-007-9004-0. - DOI
-
- Hossain M.S., Zakaria C., Kudrat-E-Zahan M. Metal complexes as potential antimicrobial agent: A review. Am. J. Heterocycl. Chem. 2018;4:1. doi: 10.11648/j.ajhc.20180401.11. - DOI